Retatrutide
- Model:1G,10G,1KG,5KG,25KG
- Createtime: 2026-07-02
- Updatetime: 2026-07-16
Product Details
| useage |
FOR R&D RESEARCH USE
|
| deliveryInfo |
|
| appearance |
white to off white powder
|
| aliasen |
|
| supplyCapacity |
50000000KG/Year
|
| harbor |
SHENZHEN
|
| minorder |
1G
|
Product Name: Retatrutide
CAS No.: 2381089-83-2
Peptide Type: Synthetic triple receptor agonist peptide, GLP-1/GIP/GCGR triple-target agonist, metabolic regulatory peptide, new drug research intermediate, scientific research biochemical reagent
Appearance: White to off-white lyophilized powder, loose and uniform texture, non-caking, odorless with ultra-low impurities
Purity: ≥98.0% (HPLC, research grade / pharmaceutical intermediate grade)
Moisture Content: ≤8.0%
Acetate Content: ≤12.0%
Peptide Content: ≥80.0%
Heavy Metals: ≤10ppm
Endotoxin: ≤50EU/mg
Solubility: Slightly soluble in water and acetonitrile, moderately soluble in DMSO and PBS buffer (pH7.2), suitable for pharmacological experimental solvent systems
Transport Condition: Sealed, light-proof and moisture-proof transportation at room temperature
Storage Condition: Long-term storage of dry powder at -20℃ in sealed, dry and dark environment; strictly avoid high temperature, strong light and moisture. Dissolved solutions must be aliquoted and frozen. Strictly avoid repeated freeze-thaw cycles to prevent attenuation of target activity
Production Technology: Standard solid-phase peptide synthesis (SPPS), precise full-length sequence assembly, multi-stage high-precision HPLC purification, low-temperature vacuum freeze-drying activity locking technology
Core Bioactivity: Triple-target activation (GLP-1R/GIPR/GCGR), glycolipid metabolism regulation, appetite suppression, fat loss and weight reduction, insulin resistance improvement, energy homeostasis regulation
Shelf Life: 24 months for sealed dry powder stored at -20℃ under standard conditions
Usage Restriction: For scientific research, metabolic pharmacological experiments, preclinical new drug development and pharmaceutical intermediate use only. Strictly prohibited for human clinical treatment, oral/injection administration and illegal applications